Who We Are

Bristol-Myers Squibb Canada is a subsidiary of the New York-based multinational, Bristol-Myers Squibb (NYSE: BMY) – a next-generation BioPharma leader focused on the research and development of innovative treatments in five key therapeutic areas: cardiovascular and metabolism, oncology, neuroscience, immunoscience and virology.

What does it mean to be BioPharma?

It means combining the best elements of an innovative biotech company while retaining the strengths of a traditional pharmaceutical company.

Our approach uniquely combines our strengths as a mid-cap pharmaceutical company – such as our scope, our reach and our breadth of experience – and the traits we most admire from biotech companies, such as agility and entrepreneurial culture.